Get MindMed Updates:
Robert Barrow
Chief Executive Officer
Daniel R Karlin, MD MA
Chief Medical Officer
Miri Halperin Wernli, PhD
Executive President and Board Director
Bradford Cross
Chief Technology Officer
Donald Gehlert, PhD
Chief Scientific Officer
Dave Guebert
Chief Financial Officer
Shahera St. John
VP, Programs
Peter Mack, PhD
VP, Pharmaceutical Development
Nico Forte
VP, Business Operations and Development
Carole Abel
VP, EU Operations & Alliances, and Program Leader LSD
Jakub Klimes
VP, Global Operations
Carol Gaines, MD
Senior Medical Director
Stephen Schneider, PhD
Sr. Director, Drug Substance Development
Lysa Triantafillou
Senior Director of Clinical Quality Assurance
Jamie Freedman
Director of Clinical Operations
Madeline Feldman
Director of Strategy & Operations
Julie Tripp
Director of Toxicology
Jamileh Jemison, MD
Digital Clinical Director
Todd Solomon, PhD
Digital Clinical Director
Martin Majernik
Director of Digital Product Lifecycle
Gennady Smagin
Director of Pharmacology
Amber Doty
Director of Pharmaceutical Development
Dustin Melton
Director of Pharmaceutical Development
Stanley D Glick, MD PhD
Scientific Advisor
Natalie Wheeler, PhD
Medical Science Liaison with Dova Pharmaceuticals
Maurizio Fava, MD
Member, Scientific Advisory Board Psychiatrist-in-Chief of the Massachusetts General Hospital (MGH)
Peter Bergethon, MD
Member, Scientific Advisory Board VP, Head of Quantitative & Clinical Technologies, Biogen, Inc.
Robert Malenka, MD PhD
Chairman of the Scientific Advisory Board, Nancy Friend Pritzker Professor in Psychiatry and Behavioral Sciences at Stanford University
Kenneth Alper, MD
Clinical Associate Professor of Psychiatry and Neurology at the New York University School of Medicine
Sarah McCallum, PhD
Associate Professor of Neuroscience and Experimental Therapeutics (DNET) at Albany Medical College
John Rotrosen, MD
Professor of Psychiatry with New York University’s Langone’s Department of Psychiatry
Robert Dworkin, PhD
Professor of Anesthesiology and Perioperative Medicine, Neurology, and Psychiatry at University of Rochester
Bryan L. Roth, MD, PhD
Professor of Pharmacology, University of North Carolina School of Medicine; Director of the National Institute of Mental Health Psychoactive Drug Screening Program
Matthew W Johnson, PhD
Clinical Advisor
Peter Gasser, MD
Clinical Advisor
Matthias Liechti, MD PhD
Scientific Collaborator & Advisor
Kim PC Kuypers, PhD
Scientific Collaborator & Advisor
Sarah Y Vinson, MD
Board Director, Member of Audit Committee
Brigid Makes
Board Director, Chair of Audit Committee, Member of Compensation, Nomination and Governance Committee
Perry Dellelce
Chairman, Member of Nomination and Governance Committees
Stephen L. Hurst, JD
Co-Founder and Board Director
Andreas Krebs
Board Director
Carol Vallone
Board Director
JR Rahn
Co-Founder
Scott Freeman, MD
Co-Founder & Clinical Advisor
Leonard Latchman
Co-Founder
Craig Conant
Associate Director, Clinical Operations
Sarah Karas
Associate Director, Clinical Science
Rachel Chasse
Sr Clinical Programs Manager
Matus Hajduk
Sr Clinical Operations Manager
Alex Deschamps
Clinical Research Coordinator
Shenique Gardner
Clinical Research Coordinator
Cordia Simmons
Clinical Trial Assistant
Jon Polaha
Financial Analyst
Klara Kleinova
People & Business Ops Specialist
Georgios Lampadariou
Senior Product Manager
Dana Rajtarova
Senior Business Development Manager
Ondrej Skala
Associate Project Manager
Tomas Stefanicka
Infrastructure Lead
Peter Dubec
Product Engineering Lead
Alexander Wald
iOS Engineer
Adam Kolar
Machine Learning Lead
Miguel Amável Pinheiro, PhD
Machine Learning Lead
Martin Pilch
Senior iOS Engineer
Branislav Rariga
Senior Designer
Ezekiel Powdar
Clinical Research Coordinator
Michal Lietava
Sr Finance Manager
Enriko Malinak
Sr Legal Specialist
Alena Vankova
Talent & People Ops Specialist
Daniel Gavin
Senior Recruiter
Maria Estrada
Executive Assistant to CEO
Wenna Wu
People & Business Ops Generalist
Michal Trebula
Finance Specialist
Libby McLean
Junior Research & Operations Specialist